Tuesday, August 3, 2021
Home Breaking News qTerm - Ambient Temperature Measurement Feature Added

qTerm – Ambient Temperature Measurement Feature Added

SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), announced that its joint Venture, GBT Tokenize Corp., is enhancing qTerm vitals device, adding an ambient temperature sensing system which the Company intends to include in its first version.

This feature is designed to sense the user’s surroundings temperature, as a reference for accuracy. qTerm will let the user know in the event the ambient temperature is not ‘optimum’ for data measurement. In case that the user is in an outdoors condition that will affect the measurement accuracy, it is designed to provide an alert. In hot or cold geographical regions, the user’s skin temperature may be elevated/declined due to the surrounding temperature. This may distort the measured data. qTerm will be able to detect and alert for such probability. Another device is intended to be added to qTerm in order to detect extreme ambient temperature and advise the user to take measurements in a more neutral or climate controlled area. A supporting firmware code will work in conjunction with this feature and an additional alerting system is planned to be embedded within the accompanied mobile app. An advanced software module will be developed for the backend program to geographically detect the user’s environment temperature according to his/her location. qTerm will include a high-precision digital temperature sensor with a low power consumption that will be used in a ‘no-contact’ fashion. The sensor is designed to measure temperatures with an accuracy of up to ±0.1°C across the range of -20°C and 50°C with no calibration. This data will be used as a confirmation reference, comparing for the actual taken measurement temperature to the reported resources, together advising the user about potential inaccuracies and switching to a better environment for optimum data results. An ambient temperature is the actual temperature of the air in any particular location, as measured by a thermal device and plays a significant factor in a human body temperature measurement. This feature is planned to be included within the first release of qTerm.

“Imagine a qTerm user that is currently located in Phoenix, AZ outdoors during summer time. The outdoor temperature will cause the user’s skin temperature to be elevated and, therefore, the data reading will be inaccurate. qTerm will alert about taking the measurement in an area of extreme surrounding temperatures, advising to go into a more climate controlled zone like indoors environment,” said Danny Rittman, GBT’s CTO. “Another example is taking the temperature in New York City in the outdoors. The user’s finger tip will be cold which will cause inaccurate results. We are implementing another circuit within our qTerm device to measure the user’s environment temperature, alerting in case of extremes. In addition, our backend program will verify the measured ambient temperature, taking the data from online resources, according to the user’s location. Together with the electronic circuit, which is a high-precision digital temperature sensor actual results, qTerm will reach a conclusion about alerting the user or not. A supporting code will be developed in order to create a pre-temp measurement procedure to ensure optimum ambient temperature before checking the body temperature. We focus on accuracy and reliability of human vitals and would like to ensure optimum conditions for data measurement. Additionally, we may use the ambient data at the ‘system’ level for further analysis purposes. qTerm AI software will be using the data to further analyze and record the user’s information for future use,” continued Danny Rittman, GBT’s CTO.

Forward-Looking Statements

Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov ). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.

Dr. Danny Rittman, CTO
GBT Technologies Inc.


This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of GBT Technologies Inc (GTCH) and does not buy, sell, or trade any shares of (GTCH). This article does not provide a professional analysis of a (GTCH) financial position. (GTCH) financial position and all other information regarding the featured Company should be verified directly with (GTCH). Please read our full disclaimer for more detailed information.

Most Popular

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient Centric...

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording &...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording...

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin(R) line of pain relief...

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs


Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts